Source: Milwaukee Journal Sentinel
Date: May 8, 2007
Summary:
A team of scientists from Advanced Cell Technology, Memorial Sloan-Kettering Cancer Center in New York and the University of Florida in Gainesville, has shown that early blood and immune cells from human embryonic stem cells can effectively target and fix vascular injuries in a mouse's body. The scientists are planning to bring these cells, called hemangioblasts, into the clinic in the next few years.
